Figure 19 T T T oT T 7 T 4 4 40 4 » gi) za ‘a TTF tT - (B) ‘tr ¥ T — Lo F T T T T 4 4 4 10 1a 32 4 5 #20 4 a f . ~s 4 a 4 4 2 PLAT 60 4 >» z % 4 4 2. Qo | 61OOUlU1300C(6200 250) | «6300 200 250 3100 350 | 400 4 7 6 4 4 4 4 “{ 2 4 ottttit tt | q aso 30. | a 7 0 4 moe i cd lg 7O a0 ao oo «63800400 1 1 4 ° o50 1o Oot FE te) 1.06 1§0 200 250 306 i ee aa 356 ee + (F) 4 ” ar - ar is . 4 2 6k “4 = “T > 4 a w t o O ot VO O02 b (G) O04 oo O68 i O8 Ln 10 #t2 [TTT] 14 i #16 #%18 TTT Tt ~ zz 6 5 ry Fk 1 : a | t cL 20 o® o80 OTT iW) ~ €F 4 be #100 #150 [ 200 bn 290 dl, 300 J 350 Tt 4 = 7 4 _ = J {+ ~ 2- “4 — = = ze rn = % - “rT 4of. i of g 4 + CC 4 oe «4 - ; 1 w 4 6r f | iL 050 100 180 2.00 250 300 330 400 450 DOSE EQUIVALENT, Rem ;o 10 20 30 40 50 (F) Adolescente on Rongelap, (E) Young Adults (G) Children and (H) Infance 40 oon FO @0 90 OOSE EQUIVALENT, Rem Fig. 19 1374, Dose Equivalent to (A} All Residents {B) Adults (C) Adult Males (D) Adult Femalea 60 =~